The cost of influenza in Thailand (Q39464451)

12 September 2017

The cost of influenza in Thailand (English)

1 reference

12 September 2017

0 references

Viroj Tangcharoensathien

8

object named as

Viroj Tangcharoensathien

1 reference

12 September 2017

4

Timothy Uyeki

1 reference

12 September 2017

5

Sonja J Olsen

1 reference

12 September 2017

James Mark Simmerman

1

1 reference

12 September 2017

Jongkol Lertiendumrong

2

1 reference

12 September 2017

Scott F Dowell

3

1 reference

12 September 2017

Malinee Chittaganpitch

6

1 reference

12 September 2017

Supamit Chunsutthiwat

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

19 January 2006

1 reference

12 September 2017

1 reference

12 September 2017

24

1 reference

12 September 2017

20

1 reference

12 September 2017

4417-4426

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

12 September 2017

1 reference

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

The impact of influenza epidemics on mortality: introducing a severity index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Economic impact of influenza vaccination in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Socioeconomic impact of influenza on healthy children and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Burden of influenza in children in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Sickness absence due to influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

The socio-economic burden of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Medical economics in the field of influenza--past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Cost-effectiveness study on influenza prevention in Hong Kong.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Influenza in Thailand: a case study for middle income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Vaccination for pandemic influenza: a six point agenda for interpandemic years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Influenza: its control in persons and populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

The friction cost method for measuring indirect costs of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

A review of the effects of colds and influenza on human performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Primary health concept revisited: where do people seek health care in a rural area of Vietnam?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Economic transition should come with a health warning: the case of Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Health impacts of rapid economic changes in Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Influenza A infection is an important cause of febrile seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Encephalitis and encephalopathy associated with an influenza epidemic in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Influenza A and B virus infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Interactions between bacteria and influenza A virus in the development of influenza pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

Effectiveness of Influenza Vaccine to Prevent Acute Otitis Media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.060

10.1016/J.VACCINE.2005.12.060

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference